CVS to Pay $315M to Settle Opioid Prescription Claims
The Facts
- CVS Pharmacy Inc. and dozens of subsidiaries agreed on Tuesday to pay $315 million to resolve U.S. Department of Justice (DOJ) allegations that they illegally filled prescriptions for opioids and other controlled substances between October 2013 and December 2025.
- The DOJ launched legal proceedings against the firm in December 2024, accusing it of dispensing excessive quantities of opioids, filling prescriptions too early and processing "trinity" combinations of an opioid, a benzodiazepine and a muscle relaxant, along with prescriptions written by "pill mill" prescribers.
- In addition, federal prosecutors accused CVS of prioritizing profits over patient safety through its performance metrics, incentive compensation and staffing policies, and of issuing prescriptions despite warnings that these were not for legitimate medical reasons.
Sources Split
LEFT
CENTER
RIGHT
+1
+1
+1
ESTAB
CRIT
CENTER
PRO
ESTAB
The Spin
Industry-critical narrative
A pharmacy counter should be the last line of defense against the opioid epidemic, not a cash register that ignores obvious red flags. When corporate quotas and understaffing push pharmacists to fill first and never ask questions, patients die and taxpayers foot the bill. Real accountability, with monitoring and reporting safeguards, has been long overdue, and this settlement delivers.
Pro-industry narrative
Pharmacists are being judged after the fact against standards the government never bothered to write down. Every prescription at issue came from a practitioner the government itself licensed to prescribe controlled substances, and voluntarily blocking suspect doctors drew lawsuits from the other direction. Squeezing pharmacies from both sides leaves patients in real pain with nowhere to turn.
